Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 14559877)

Published in J Natl Cancer Inst on October 15, 2003

Authors

Dawn Hershman1, Mitchell Weinberg, Zachary Rosner, Karenza Alexis, Amy Tiersten, Victor R Grann, Andrea Troxel, Alfred I Neugut

Author Affiliations

1: Department of Medicine and the Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, New York, NY, USA. dlh23@columbia.edu

Associated clinical trials:

Palbociclib / Letrozole in African American Women With HR+ HER2- Breast Cancer (PALINA) | NCT02692755

Articles citing this

Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood (2005) 3.77

Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene. PLoS Genet (2009) 3.60

Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. J Clin Oncol (2009) 2.61

Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc (2008) 2.46

Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer. J Clin Oncol (2008) 1.88

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol (2008) 1.61

Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity. J Natl Cancer Inst (2013) 1.11

An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials. J Cancer Res Clin Oncol (2007) 1.03

Breast cancer and the immune system. J Soc Integr Oncol (2008) 1.03

Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. Clin Gastroenterol Hepatol (2008) 1.00

Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship. Breast Cancer Res Treat (2013) 1.00

Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy? J Clin Oncol (2010) 0.94

Prevalence, phenotype and inheritance of benign neutropenia in Arabs. BMC Blood Disord (2009) 0.93

Impact of age, gender, and race on circulating γδ T cells. Hum Immunol (2010) 0.92

Genome science and health disparities: a growing success story? Genome Med (2013) 0.90

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing. Breast Cancer Res Treat (2015) 0.89

Social and ethical implications of genomics, race, ethnicity, and health inequities. Semin Oncol Nurs (2008) 0.85

Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B. J Clin Oncol (2008) 0.85

A cluster randomized controlled trial to increase breast cancer screening among African American women: the black cosmetologists promoting health program. J Natl Med Assoc (2011) 0.82

Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system. Int J Breast Cancer (2012) 0.79

Association of socioeconomic and practical unmet needs with self-reported nonadherence to cancer treatment appointments in low-income Latino and Black cancer patients. Ethn Health (2015) 0.78

Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival. Clin Cancer Res (2016) 0.77

Prevalence of neutropenia in children by nationality. BMC Hematol (2016) 0.77

Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes. Curr Opin HIV AIDS (2010) 0.76

Comparison of absolute neutrophil to CD4 lymphocyte values as a marker of immunosuppression in cancer patients on cytotoxic chemotherapy. Afr Health Sci (2015) 0.76

An update on the management of breast cancer in Africa. Infect Agent Cancer (2017) 0.75

Investigating racial disparities in use of NK1 receptor antagonists to prevent chemotherapy-induced nausea and vomiting among women with breast cancer. Breast Cancer Res Treat (2016) 0.75

Analysis of overall survival in a large multiethnic cohort reveals absolute neutrophil count of 1,100 as a novel prognostic cutoff in African Americans. Oncotarget (2016) 0.75

Socioeconomic and racial disparities in the selection of chest wall boost radiation therapy in californian women after mastectomy. Clin Breast Cancer (2014) 0.75

Examining racial variation in antiemetic use and post-chemotherapy health care utilization for nausea and vomiting among breast cancer patients. Support Care Cancer (2016) 0.75

Articles by these authors

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest (2003) 16.67

Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. J Natl Cancer Inst (2007) 4.97

Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. JAMA (2013) 4.67

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol (2010) 4.43

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31

Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst (2003) 3.71

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat (2010) 3.35

Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med (2009) 3.33

Racial disparities in treatment and survival among women with early-stage breast cancer. J Clin Oncol (2005) 3.02

Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Cancer Epidemiol Biomarkers Prev (2002) 2.83

The impact of suboptimal bowel preparation on adenoma miss rates and the factors associated with early repeat colonoscopy. Gastrointest Endosc (2011) 2.73

The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat (2002) 2.71

Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol (2007) 2.69

Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. J Clin Oncol (2012) 2.59

Use of the Internet by women with breast cancer. J Med Internet Res (2003) 2.46

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer (2006) 2.36

Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa. Cancer Epidemiol Biomarkers Prev (2008) 2.29

Facilitating cancer research using natural language processing of pathology reports. Stud Health Technol Inform (2004) 2.28

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat (2006) 2.26

Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J Clin Oncol (2006) 2.26

Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort. J Natl Cancer Inst (2007) 2.24

Trends in relative survival for ovarian cancer from 1975 to 2011. Obstet Gynecol (2015) 2.22

Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. J Clin Oncol (2012) 2.21

Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. J Clin Oncol (2005) 2.11

Epidemiology of upper gastrointestinal malignancies. Semin Oncol (2004) 2.10

Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10

Electric blanket use and breast cancer on Long Island. Epidemiology (2003) 2.06

Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol (2013) 2.05

Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci (2010) 2.04

Associations between breast cancer risk and the catalase genotype, fruit and vegetable consumption, and supplement use. Am J Epidemiol (2005) 2.03

The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. J Neurosurg (2013) 2.01

Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol (2011) 2.00

Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol (2012) 1.98

Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev (2004) 1.96

Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93

Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89

Lifetime alcohol intake and breast cancer risk. Ann Epidemiol (2005) 1.85

Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85

Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol (2008) 1.83

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma. Cancer (2005) 1.78

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys (2006) 1.77

High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges. Eur Urol (2006) 1.76

Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States. Clin Gastroenterol Hepatol (2009) 1.76

Weight gain prior to diagnosis and survival from breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.73

Trends in hospital volume and patterns of referral for women with gynecologic cancers. Obstet Gynecol (2013) 1.72

Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years. Gastroenterology (2008) 1.71

Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer (2009) 1.70

Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68

Internet use and social support in women with breast cancer. Health Psychol (2002) 1.67

Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol (2011) 1.66

HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis. Epidemiology (2010) 1.63

Lung cancer risk in white and black Americans. Ann Epidemiol (2003) 1.63

Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean. Br J Haematol (2008) 1.61

Diabetes mellitus and the risk of prostate cancer. Cancer Invest (2002) 1.60

Effect of surgical volume on outcomes for laparoscopic hysterectomy for benign indications. Obstet Gynecol (2012) 1.58

Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. JAMA Surg (2013) 1.57

Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57

Health belief model factors in mammography screening: testing for interactions among subpopulations of Caribbean women. Ethn Dis (2005) 1.55

Trends in surgical mesh use for pelvic organ prolapse from 2000 to 2010. Obstet Gynecol (2012) 1.55

Effect of a patient navigator program on the volume and quality of colonoscopy. J Clin Gastroenterol (2011) 1.54

Prior endoscopy in patients with newly diagnosed celiac disease: a missed opportunity? Dig Dis Sci (2013) 1.53

Prostate cancer screening behavior in men from seven ethnic groups: the fear factor. Cancer Epidemiol Biomarkers Prev (2006) 1.52

Cardiovascular Disease Mortality Among Breast Cancer Survivors. Epidemiology (2016) 1.52

Fruits, vegetables, and micronutrients in relation to breast cancer modified by menopause and hormone receptor status. Cancer Epidemiol Biomarkers Prev (2004) 1.52

Adherence to biopsy guidelines increases celiac disease diagnosis. Gastrointest Endosc (2011) 1.52

Choline metabolism and risk of breast cancer in a population-based study. FASEB J (2008) 1.51

Racial differences in quality of life following prostate cancer diagnosis. Urology (2010) 1.51

Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev (2002) 1.50

Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2006) 1.48

Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev (2002) 1.48

Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer. Clin Cancer Res (2012) 1.46

Variation in ovarian conservation in women undergoing hysterectomy for benign indications. Obstet Gynecol (2013) 1.46

Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol (2005) 1.46

Environmental tobacco smoke and breast cancer incidence. Environ Res (2004) 1.45

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol (2002) 1.44

Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev (2005) 1.44

Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiol Biomarkers Prev (2009) 1.44

Hospital information systems and clinical cancer research. Cancer Invest (2004) 1.44

Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. J Clin Oncol (2008) 1.44

Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) (2009) 1.44

One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res (2005) 1.38

The contribution of emotional characteristics to breast cancer screening among women from six ethnic groups. Prev Med (2004) 1.36

Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. J Clin Oncol (2002) 1.34

Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Public Health (2003) 1.33

Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat (2010) 1.31

Reproductive factors and breast cancer risk among older women. Breast Cancer Res Treat (2006) 1.30

Associations between perceived cancer risk and established risk factors in a national community sample. Cancer Detect Prev (2004) 1.26

Pancreatic proteolytic enzyme therapy compared with gemcitabine-based chemotherapy for the treatment of pancreatic cancer. J Clin Oncol (2009) 1.24